Ensera Launches Alliance Network to Streamline Combination Drug-Device Supply
Image
Dublin – – October 01, 2026 -- Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, uniting device platform and fill-finish specialists to streamline the commercialization of drug-device combination products.
Five specialist firms join the new coordination network
The network currently comprises injector platform providers SHL Medical, Stevanato Group and Ypsomed, alongside fill-finish specialists Argonaut Manufacturing Services and American Injectables. Ensera said it plans to expand the network over time by adding organizations whose capabilities and standards complement existing members.